Table of contents

Extended reports

• Combined high-resolution magnetic resonance imaging and histological examination to explore the role of ligaments and tendons in the phenotypic expression of early hand osteoarthritis (20 April, 2006) Free

  A L Tan, H Toumi, M Benjamin, A J Grainger, S F Tanner, P Emery, D McGonagle
• Genetic characterisation of spontaneous ankylosing arthropathy with unique inheritance from Fas-deficient strains of mice (28 March, 2006)

  S Mori, M-C Zhang, N Tanda, F Date, M Nose, H Furukawa, M Ono
• Expression of the peptide C4b-binding protein β in the arthritic joint (5 May, 2006)

  O Sánchez-Pernaute, J Esparza-Gordillo, R Largo, E Calvo, M A Alvarez-Soria, M E Marcos, G Herrero-Beaumont, S R de Córdoba
• Pretreatment macrophage infiltration of the synovium predicts the clinical effect of both radiation synovectomy and intra-articular glucocorticoids (20 April, 2006)

  Z N Jahangier, J W G Jacobs, M C Kraan, M J G Wenting, T J Smeets, J W J Bijlsma, F P J G Lafeber, P P Tak
• Altered gut transcriptome in spondyloarthropathy (13 February, 2006)

  D Laukens, H Peeters, B V Cruyssen, T Boonefaes, D Elewaut, F De Keyser, H Mielants, C Cuvelier, E M Veys, K Knecht, P Van Hummelen, E Remaut, L Steidler, M De Vos, P Rottiers
• EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT) (17 May, 2006)

  W Zhang, M Doherty, E Pascual, T Bardin, V Barskova, P Conaghan, J Gerster, J Jacobs, B Leeb, F Lioté, G McCarthy, P Netter, G Nuki, F Perez-Ruiz, A Pignone, J Pimentão, L Punzi, E Roddy, T Uhlig, I Zimmermann-Gòrska
• EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT) (17 May, 2006) Free

  W Zhang, M Doherty, T Bardin, E Pascual, V Barskova, P Conaghan, J Gerster, J Jacobs, B Leeb, F Lioté, G McCarthy, P Netter, G Nuki, F Perez-Ruiz, A Pignone, J Pimentão, L Punzi, E Roddy, T Uhlig, I Zimmermann-Gòrska
• Minimally important difference in diffuse systemic sclerosis: results from the d-penicillamine study

  (15 March, 2006)

  D Khanna, D E Furst, R D Hays, G S Park, W K Wong, J R Seibold, M D Mayes, B White, F F Wigley, M Weisman, W Barr, L Moreland, T A Medsger, V D Steen, R W Martin, D Collier, A Weinstein, E V Lally, J Varga, S R Weiner, B Andrews, M Abeles, P J Clements
• The Met66 allele of the functional Val66Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemic lupus erythematosus (10 April, 2006)

  G Oroszi, L Lapteva, E Davis, C H Yarboro, T Weickert, T Roebuck-Spencer, J Bleiberg, D Rosenstein, M Pao, P E Lipsky, D Goldman, R H Lipsky, G G Illei
• Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions (22 June, 2006)

  C P Denton, M Humbert, L Rubin, C M Black
• Cutaneous abnormalities in rheumatoid arthritis compared with non-inflammatory rheumatic conditions (13 February, 2006)

  K M J Douglas, E Ladoyanni, G J Treharne, E D Hale, N Erb, G D Kitas
• Indications for total hip replacement: comparison of assessments of orthopaedic surgeons and referring physicians (26 January, 2006)

  K E Dreinhöfer, P Dieppe, T Stürmer, D Gröber-Grätz, M Flören, K-P Günther, W Puhl, H Brenner
• Differential expression patterns of recombination-activating genes in individual mature B cells in juvenile idiopathic arthritis (27 February, 2006)

  C Faber, H Morbach, S K Singh, H J Girschick
• Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison (10 April, 2006)

  B Combe, C Codreanu, U Fiocco, M Gaubitz, P P Geusens, T K Kvien, K Pavelka, P N Sambrook, J S Smolen, J Wajdula, S Fatenejad
• Clinical classification criteria for knee osteoarthritis: performance in the general population and primary care (20 April, 2006)

  G Peat, E Thomas, R Duncan, L Wood, E Hay, P Croft
• Sex differences in gout epidemiology: evaluation and treatment (27 April, 2006)

  L R Harrold, R A Yood, T R Mikuls, S E Andrade, J Davis, J Fuller, K A Chan, D Roblin, M A Raebel, A Von Worley, R Platt, K G Saag
• Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors (27 April, 2006)

  J Fransen, C Antoni, P J Mease, W Uter, A Kavanaugh, J R Kalden, P L C M Van Riel
• Adalimumab and methotrexate is more effective than adalimumab alone in patients with established rheumatoid arthritis: results from a 6-month longitudinal, observational, multicentre study (5 May, 2006)

  M S Heiberg, E Rødevand, K Mikkelsen, C Kaufmann, A Didriksen, P Mowinckel, T K Kvien
• Radiation synovectomy with yttrium-90 for persisting arthritis has direct harmful effects on human cartilage that cannot be prevented by co-administration of glucocorticoids: an in vitro study (27 April, 2006)

  Z N Jahangier, K M G Jacobs, J W J Bijlsma, F P J G Lafeber